Beauty Health Co (SKIN) Fair Value & Analysis
Consumer Defensive · US · Market cap $85.7M · ISIN US88331L1089
What is Beauty Health Co really worth?
Beauty Health Co
SKIN · US
A solid business, trading 71% below our fair value of $2.35.
As of Aug 30, 2026, the fair value of Beauty Health Co is $2.35 per share against a price of $0.6850, so the fair value sits 243% above the price. A model estimate blended from multiple valuation models, recalculated regularly.
Risks
Fair value as of: Aug 30, 2026
From 12 valuation models · updated 7 days ago
Share price −2.8% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price is below even our cautious bear case ($1.31). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range ($1.31 to $3.40) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.
How to read this chart
60‑month range $0.5800 – $29.49 · fair‑value band $1.31 – $3.40 · the $0.6850 price screens below the $2.35 fair value. Dashed = 300-day average. As of Aug 30, 2026.
Analysis
Beauty Health Co (SKIN) currently trades at $0.6850, while our model-based Fair Value estimate is $2.35, implying the stock looks roughly 70.9% undervalued today. The Quality Score stands at 61/100 (solid quality), in the Consumer Defensive sector. Bull case: the Multiples group reads highest at a median of $3.42 per share, and 9 of the 12 models we run sit above the $0.6850 price. Bear case: the Asset-Based group reads lowest at $0.3200, and 3 of the 12 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, Beauty Health Co generated revenue of $296M at a net margin of −2.0%. Revenue declined 6.7% year over year. It earns a return on equity of −12.0%. Net debt stands at $146M. Fundamentals as of Aug 30, 2026
Our scenario range runs from $1.31 (bear case) to $3.40 (bull case); at $0.6850, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 75% below its 52-week high and 24% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −36% fair-value upside, at 243%, SKIN screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 12 models by family
Widest divergence: Multiples ($3.42) versus Dividend Discount ($0.0200). Highest evidence: FCF DCF (80).
Notify me when SKIN reaches fair value
Put SKIN on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 19
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America.
Full company description
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Beauty Health Co reported revenue of $301M in FY2025 versus $260M in FY2021, a compound +3.7%/yr. Reported net income was −$9.5M in FY2025.
Watch SKIN: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 245 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| L'Oréal S.A LORL | C$24.76 | C$22.64 | −9% |
| Unilever PLC UNA | €55.92 | €40.47 | −28% |
| Colgate-Palmolive Company CL | $90.75 | $55.28 | −39% |
| 500696 500696 | ₹2,093 | ₹641.55 | −69% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | −61% |
| Kenvue Inc KVUE | $18.95 | $10.97 | −42% |
| Kimberly-Clark Corporation KMB | $109.55 | $79.71 | −27% |
| Henkel AG HEN3 | €76.42 | €85.95 | +12% |
| The Estée Lauder Companies Inc ESLA | €86.54 | €18.84 | −78% |
| Church & Dwight Co CHD | $101.26 | $65.12 | −36% |
Compare Beauty Health Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Beauty Health Co (SKIN) overvalued or undervalued?
What is the fair value of SKIN?
What is the quality score of SKIN?
What is the price target for Beauty Health Co (SKIN)?
What is the Beauty Health Co stock forecast for 2026?
What is the revenue of Beauty Health Co (SKIN)?
What is the net profit margin of SKIN?
Does Beauty Health Co pay a dividend?
Watch Beauty Health Co in the live analysis
One click puts Beauty Health Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.